Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses
oleh: Ian Macreadie, Sudip Dhakal, Ryan Case, Melissa Carabott
| Format: | Article |
|---|---|
| Diterbitkan: | CSIRO Publishing 2021-01-01 |
Deskripsi
The extensive and on-going epidemiology studies of the SARS-CoV-2 pandemic have raised interesting observations on statins reducing COVID-19 severity. In this review, literature is analysed to examine how statins affect COVID-19 and influenza A, another pandemic respiratory virus. This information could be useful to prevent or reduce disease severity caused by respiratory viruses.